fluorometholone has been researched along with Dry Eye in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, B; Ke, LN; Liu, XX; Nan, KH; Wang, JJ; Wang, TZ | 1 |
| Chen, W; Deng, Y; Jiang, H; Li, S; Peng, L; Wang, J; Wang, Q; Xiao, P; Yuan, J; Zhong, J | 1 |
| Aapola, U; Beuerman, R; Calonge, M; Enríquez-de-Salamanca, A; González-García, MJ; Jylhä, A; López-Miguel, A; Nättinen, J; Nykter, M; Pinto-Fraga, J; Stern, ME; Uusitalo, H; Zhou, L | 1 |
| Calder, V; Calonge, M; Enríquez-de-Salamanca, A; Fernández, I; García-Vázquez, C; González-García, MJ; López-de la Rosa, A; López-Miguel, A; Pinto-Fraga, J; Stern, ME | 1 |
| Sharma, A; Taniguchi, J | 1 |
| Jee, D; Kim, EC; Kim, MS; Lee, HJ; Park, M | 1 |
| Lee, NY; Lyu, B; Oh, SH; Yim, HB | 1 |
| Chen, S; Jiang, Y; Li, Y; Yu, C | 1 |
| Calonge, M; Enríquez-de-Salamanca, A; Fernández, I; González-García, MJ; López-de-la-Rosa, A; López-Miguel, A; Pinto-Fraga, J; Stern, ME | 1 |
| Jung, JC; Jung, SY; Kim, YH; Lee, KW; Park, YJ; Yu, S | 1 |
| Estevez, J; Pesudovs, K | 1 |
| Chae, JJ; Chuck, RS; Hongyok, T; Li, L; Na, D; Shin, YJ | 1 |
| Chuck, RS; Zhang, C; Zhu, L | 1 |
| Avunduk, AM; Avunduk, MC; Kaufman, HE; Varnell, ED | 1 |
| Gu, YS; Sun, W; Yang, CQ | 1 |
| Liang, L; Liu, Z; Zhang, M; Zou, W | 1 |
6 trial(s) available for fluorometholone and Dry Eye
| Article | Year |
|---|---|
Topical fluorometholone treatment and desiccating stress change inflammatory protein expression in tears.
Topics: Administration, Ophthalmic; Aged; Biomarkers; Calcium-Binding Proteins; Complement C3; Conjunctival Diseases; Double-Blind Method; Dry Eye Syndromes; Eye Proteins; Female; Fluorometholone; Glucocorticoids; Humans; Hyperemia; Male; Middle Aged; Proteomics; Stress Disorders, Traumatic, Acute; Tears | 2018 |
Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial.
Topics: Biomarkers; Cytokines; Double-Blind Method; Dry Eye Syndromes; Female; Fluorometholone; Glucocorticoids; Humans; Male; Middle Aged; Tears | 2018 |
Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Catalase; Drug Combinations; Dry Eye Syndromes; Female; Fluorometholone; Glucocorticoids; Humans; Hyaluronic Acid; Interleukin-1beta; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Postoperative Care; Preservatives, Pharmaceutical; Superoxide Dismutase; Tears; Tumor Necrosis Factor-alpha; Viscosupplements | 2015 |
[Comparison of clinical effects of bromfenac sodium ophthalmic solution 0.1% versus glucocorticoids for post-LASEK usage].
Topics: Benzophenones; Bromobenzenes; Corneal Topography; Dexamethasone; Drug Administration Schedule; Dry Eye Syndromes; Fluorometholone; Glucocorticoids; Humans; Intraocular Pressure; Keratectomy, Subepithelial, Laser-Assisted; Ophthalmic Solutions; Postoperative Period; Prospective Studies; Statistics, Nonparametric; Surgical Flaps; Tonometry, Ocular; Visual Acuity | 2015 |
Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial.
Topics: Administration, Topical; Conjunctiva; Cornea; Dehydration; Dose-Response Relationship, Drug; Double-Blind Method; Dry Eye Syndromes; Female; Fluorometholone; Glucocorticoids; Humans; Male; Middle Aged; Treatment Outcome | 2016 |
The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study.
Topics: Administration, Topical; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Conjunctiva; Dry Eye Syndromes; Female; Fluorescein; Fluorometholone; Flurbiprofen; Glucocorticoids; Goblet Cells; HLA-DR Antigens; Humans; Male; Middle Aged; Ophthalmic Solutions; Periodic Acid-Schiff Reaction; Prospective Studies; Rose Bengal; Single-Blind Method; Treatment Outcome | 2003 |
10 other study(ies) available for fluorometholone and Dry Eye
| Article | Year |
|---|---|
A topical fluorometholone nanoformulation fabricated under aqueous condition for the treatment of dry eye.
Topics: Cornea; Dry Eye Syndromes; Fluorometholone; Humans; Nanoparticles; Ophthalmic Solutions | 2022 |
Conjunctival microvascular responses to anti-inflammatory treatment in patients with dry eye.
Topics: Adult; Aged; Anti-Inflammatory Agents; Blood Flow Velocity; Case-Control Studies; Conjunctiva; Dry Eye Syndromes; Female; Fluorometholone; Hemodynamics; Humans; Male; Microcirculation; Middle Aged; Time Factors; Treatment Outcome; Young Adult | 2020 |
Fluorometholone modulates gene expression of ocular surface mucins.
Topics: Blotting, Western; Cells, Cultured; Conjunctiva; Dry Eye Syndromes; Epithelium, Corneal; Fluorometholone; Gene Expression Regulation; Glucocorticoids; Humans; Mucins; RNA, Messenger | 2019 |
Lower Lid Laxity is Negatively Correlated with Improvement of the Ocular Surface Disease Index in Dry Eye Treatment.
Topics: Corneal Diseases; Cyclosporine; Dry Eye Syndromes; Eyelids; Female; Fluorometholone; Glucocorticoids; Humans; Immunosuppressive Agents; Lubricant Eye Drops; Male; Middle Aged; Oculomotor Muscles; Surveys and Questionnaires; Tears | 2016 |
Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease.
Topics: Administration, Topical; Animals; Benzalkonium Compounds; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Dry Eye Syndromes; Epithelium, Corneal; Female; Fluorescent Antibody Technique, Indirect; Fluorometholone; Glucocorticoids; HLA-DR Antigens; In Situ Nick-End Labeling; Interleukin-6; Mice; Mice, Inbred C57BL; Ophthalmic Solutions; Preservatives, Pharmaceutical; Treatment Outcome; Tumor Necrosis Factor-alpha | 2016 |
Re: Pinto-Fraga et al.: Topical fluorometholone protects the ocular surface of dry eye patients from desiccating stress: a randomized controlled clinical trial (Ophthalmology 2016;123:141-153).
Topics: Administration, Topical; Dry Eye Syndromes; Eye; Fluorometholone; Humans; Ophthalmic Solutions | 2017 |
Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
Topics: Acetylcysteine; Administration, Topical; Animals; Blinking; Botulinum Toxins; Botulinum Toxins, Type A; Chitosan; Conjunctiva; Cornea; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescent Antibody Technique, Indirect; Fluorometholone; Lacrimal Apparatus; Mice; Mice, Inbred CBA; Ophthalmic Solutions; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tears | 2009 |
Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Botulinum Toxins; Botulinum Toxins, Type A; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Fluorometholone; Glucocorticoids; Interleukin-1beta; Ketorolac; Lacrimal Apparatus; Mice; Mice, Inbred CBA; Ophthalmic Solutions; Phenylacetates; Tears; Tumor Necrosis Factor-alpha | 2012 |
A clinical study of the efficacy of topical corticosteroids on dry eye.
Topics: Administration, Topical; Adult; Dry Eye Syndromes; Female; Fluorometholone; Glucocorticoids; Humans; Male; Middle Aged | 2006 |
Aggravated dry eye after laser in situ keratomileusis in patients with Sjögren syndrome.
Topics: Adult; Combined Modality Therapy; Drug Therapy, Combination; Dry Eye Syndromes; Female; Fluorometholone; Humans; Keratomileusis, Laser In Situ; Lacrimal Apparatus; Myopia; Ophthalmic Solutions; Serum; Sjogren's Syndrome; Tears | 2008 |